We are Sorry, This Page doesn't Exist
Week In Review: Concord Medical Raises $240 Million For China Radiology Services
Week In Review: Concord Medical Raises $240 Million For China Radiology Services.....»»
Week In Review: Terns Raises $80 Million For China, Global Development Of Drugs Licensed From Lilly
Week In Review: Terns Raises $80 Million For China, Global Development Of Drugs Licensed From Lilly.....»»
Week In Review: China Resources And Charoen Pokphand Join To Launch $300 Million Life Science Fund
Week In Review: China Resources And Charoen Pokphand Join To Launch $300 Million Life Science Fund.....»»
Indy VC firm High Alpha raises $110M fund
One of the top venture capital firms in the Midwest has reloaded with a new fund to back more early-stage startups. High Alpha, an Indianapolis-based VC firm, announced the close of a new $110 million fund this week. It's High Alpha's third fund.....»»
In the money Feb. 15: Nearly $153M in deals, plus a new $60M VC fund
Publicly traded companies developing tests and treatments for cancer led capital raises this past week, as 11 Austin-area companies in all reported securing about $152.7 million in deals. Additionally, a venture capital firm investing in heavy industries.....»»
Form D Friday: Denver-based private equity fund raises $34 million
Several other real estate funds were raised this week......»»
Week In Review: AstraZeneca Announces $1 Billion Fund For China Life Science Startups
Week In Review: AstraZeneca Announces $1 Billion Fund For China Life Science Startups.....»»
Week In Review: Taimei Raises $212 Million For AI Life Science Support Software
Week In Review: Taimei Raises $212 Million For AI Life Science Support Software.....»»
Fidelity to review ties with money manager after "inappropriate" comments
Fidelity Investments criticized money manager Kenneth Fisher on Tuesday over what it called inappropriate remarks he made at an investment conference last week, saying it was reviewing the $500 million Fisher's firm manages for the mutual fund giant......»»
Week In Review: Frontage, A U.S.-China CRO, Stages $205 Million Hong Kong IPO
Week In Review: Frontage, A U.S.-China CRO, Stages $205 Million Hong Kong IPO.....»»
Week In Review: MGI Tech Raises $200 Million To Manufacture Genomic Sequencing Machines
Week In Review: MGI Tech Raises $200 Million To Manufacture Genomic Sequencing Machines.....»»
Week In Review: Everest In-Licenses An ADC From Immunomedics In $835 Million Agreement, A China Record For A Single Asset
Week In Review: Everest In-Licenses An ADC From Immunomedics In $835 Million Agreement, A China Record For A Single Asset.....»»
Form D Friday: Denver firm raises $23 million for real estate fund
There were several other companies that raised money this week......»»
Week In Review: Grail, An Oncology Diagnostics Company, Taps China Investors For $300 Million
Week In Review: Grail, An Oncology Diagnostics Company, Taps China Investors For $300 Million.....»»
Week In Review: Mevion Medical Of Boston Closes $150 Million Financing From China Investors
Week In Review: Mevion Medical Of Boston Closes $150 Million Financing From China Investors.....»»
Week In Review: CStone Acquires China Rights To Leukemia Drug In $424 Million Deal
Week In Review: CStone Acquires China Rights To Leukemia Drug In $424 Million Deal.....»»
iSelect raises $3.7 million for new fund
iSelect's investments focus on biotechnology, agriculture and healthcare......»»
Week In Review: BioSense Exercises $75 Million Option For China Rights To Neovacs" Lupus Immunotherapy
Week In Review: BioSense Exercises $75 Million Option For China Rights To Neovacs" Lupus Immunotherapy.....»»
Week In Review: bioMérieux Acquires Majority Stake In China Diagnostics Company For $114 Million
Week In Review: bioMérieux Acquires Majority Stake In China Diagnostics Company For $114 Million.....»»
Week In Review: China Life Science Starts Off 2019 With $425 Million In Deals
Week In Review: China Life Science Starts Off 2019 With $425 Million In Deals.....»»